hotspot -WSS

hotspot

author：Wikipedia 2025-10-03 00:38:21 - browse：1

A medical insurance document printed with the words "COPAY," "DEDUCTIBLE," "COINSURANCE," "NON-COVERED," next to a pen — coverage from STAT — Adobe

WASHINGTON — Insurers will have to count drug copay coupons toward deductibles and patient spending caps in most cases, after a Biden move in federal court on Tuesday.

Drug companies use copay coupons to help patients cover the cost of their drugs.

Before now, when drug companies helped patients pay their share of drug costs, insurers often didn’t count that assistance toward deductibles and out-of-pocket limits. In insurance jargon, this tactic is called a copay accumulator. Previously, the practice was only allowed when drug companies give coinsurance assistance for brand drugs with generic competition. The Trump administration let insurers use the tactic when cheaper generics were not available.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Despite FDA concern, risk that CAR

leisure time

WSS

Pfizer highlights cancer drugs it thinks could reignite investor interest

ReNAgade cuts staff seven months after raising $300 million

RaDonda Vaught to speak at CommonSpirit event on patient safety

Rep. Raul Ruiz on the physician shortage and more

International team creates first chimeric human

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

focus

hotspot

hotspot

Bright Health sells Medicare Advantage business to Molina

RSV vaccines may be linked to small increased risk of developing GBS

Trump demands the U.S. pay no more for drugs than other countries … again

How to address the problem of discarded donor organs

In Memoriam: Notable people who died in 2023

FDA investigates CAR

BioMarin wins approval for gene therapy to treat hemophilia A

The EPA's new lead rule: How one expert crunched the numbers

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

knowledge

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Kenai launches with $82 million for Parkinson’s stem cell therapy

J&J to emphasize cancer drugs, stop much of its vaccine research

How to fix the rural physician shortage in the U.S.

Despite FDA concern, risk that CAR

leisure time

hotspot

leisure time

focus